ANTIVIRAL & ANTIBACTERIAL DRUG COMPANIES: EDWARD NASH - STIFEL, NICOLAUS & COMPANY INC - The Wall Street Transcript

The Wall Street Transcript - In-Depth Interviews for Investors

Healthcare >> Analyst Interviews >> July 3, 2006

TWST: Let's start with an overview of what you are covering in the

biotech sector.

Mr. Nash: Right now, we are covering roughly 17 names. About 70% to 75%

of those names are focused on

Join for free to read a longer excerpt or purchase this article